Skip to main content
Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.
Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality.
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach.